Effect of bilirubin on visuocortical development in preterm infants

William V Good1,2, Ronald J Wong3, Anthony M Norcia4

  • 1The Smith-Kettlewell Eye Research Institute, San Francisco, CA, USA. Good@ski.org.

Insights

High bilirubin levels significantly impact visuocortical development in premature infants, particularly those born before 34 weeks gestation. Vernier acuity is notably affected, suggesting a need to revise hyperbilirubinemia management guidelines for these vulnerable infants.

Area of Science:

  • Neonatal neurology
  • Developmental pediatrics
  • Visual neuroscience

Background:

  • High bilirubin levels (hyperbilirubinemia) pose a risk to infant neurodevelopment.
  • The impact of hyperbilirubinemia on visuocortical development in premature infants requires further investigation.

Purpose of the Study:

  • To compare the effects of high bilirubin levels on visuocortical development between premature and full-term infants.
  • To identify specific visual functions most vulnerable to bilirubin toxicity in preterm neonates.

Main Methods:

  • A cohort of 57 preterm infants was studied, adhering to institutional hyperbilirubinemia management protocols.
  • Visual functions including Vernier acuity, contrast sensitivity, and grating acuity were assessed at 12 months corrected age using sweep visual evoked potentials (sVEP).
  • These visual measures were correlated with total serum/plasma bilirubin (TSB) levels recorded in the first week of life.

Main Results:

  • Increased TSB levels correlated with worsened Vernier acuity in infants born before 34 weeks gestation compared to those born between 34-37 weeks (p < 0.001).
  • Contrast sensitivity showed a significant variation related to TSB levels (Spearman correlation 0.63, p < 0.001).
  • Grating acuity did not appear to be affected by TSB levels.

Conclusions:

  • Vernier acuity in preterm infants (<34 weeks gestation) is particularly susceptible to bilirubin's adverse effects.
  • These findings suggest that the extrastriate visual cortex is a primary target of bilirubin toxicity in this population.
  • Current guidelines for managing hyperbilirubinemia in preterm infants (<34 weeks gestation) may need revision to better protect visual development.
Abstract